Neo-adjuvant Chemotherapy
Role of Neo Adjuvant Chemotherapy in the Treatment of Osteosarcoma
... with neo-adjuvant chemotherapy which could be a bias on our ...without neo-adjuvant ...MRI, neo-adjuvant chemotherapy may offer some advantage regarding ...
5
Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo adjuvant chemotherapy in locally advanced breast cancer a prospective study
... of neo-adjuvant chemotherapy (cyclophosphamide, adriamycin, 5-fluorouracil) were subjected to SLNB (using methylene blue dye) followed by complete axillary lymph node dissection (levels ...
7
Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo adjuvant chemotherapy in patients with triple negative breast cancer
... Research on factors about response to neo-adjuvant chemotherapy appeared to be important. Factors which were studied more included ER, HER2/neu, P53, Ki67 etc. Conclusions were reached differently on ...
7
Effects of neo adjuvant chemotherapy for oesophago gastric cancer on neuro muscular gastric function
... In summary, our study suggests that neo-adjuvant chemotherapy can cause marked and enduring damage to neuro-muscular gastric function. Most notable was the loss of AChE and reduction in contractility ...
16
Original Article Inter- and intra-observer reliability in histologic evaluation of necrosis rate induced by neo-adjuvant chemotherapy for osteosarcoma
... following neo-adjuvant chemotherapy is one of the most important prog- nostic factors for patients with osteosarcoma, and it also provides the basis for selection of postoperative adjuvant ...
9
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
... after neo-adjuvant chemotherapy plus somatostatin ...that neo-adjuvant chemotherapy may be beneficial to gallbladder mixed neuroendocrine carcinomas in an advanced stage which ...
6
Phase II study of neo adjuvant chemotherapy for locally advanced gastric cancer
... Prior to treatment, the patients underwent laboratory evaluation, CT of the abdomen/pelvis, chest X-ray (or CT chest for GEC tumours), esophagogastroduodeno- scopy (EGD) with EUS and staging laparoscopy with peritoneal ...
7
Role of neo-adjuvant chemotherapy in downstaging carcinoma breast
... systemic chemotherapy can result in a considerable decline in tumor size in 50% to 80% of patients with ...This neo adjuvant therapy can convert inoperable tumors to operable ...ones. Neo ...
100
Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer.
... This study was limited by its relatively modest size and single institution, retrospective design. Thirty percent of cases assessed for RCB did not have pre-treatment samples available for analysis due to a significant ...
6
Original Article Identifying dihydrofolate reductase as a predictor for poor response to neoadjuvant chemotherapy in breast cancer patients
... Neoadjuvant chemotherapy was administrated in all the patients after ...neoadjuvant chemotherapy were collected for further ...after neo- adjuvant chemotherapy was defined as patho- ...
8
Original Article Role of ifosfamide chemotherapy for patients with non-metastatic osteosarcoma: a meta-analysis with 1724 patients
... Our results revealed that IFO cannot increase the histological response rate when added to neo-adjuvant chemotherapy. This finding was not consistent with previous studies in which regimens with 4 ...
13
NEOADJUVANT CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK REGION: A SINGLE INSTITUTIONAL STUDY
... without neo- adjuvant chemotherapy are both viable treatment options in locally advanced ...with neo- adjuvant chemotherapy followed by concurrent chemoradiation and followed for ...
9
Synovial sarcoma of the maxillary sinus: an extremely rare case with excellent response to chemotherapy
... of chemotherapy is not well ...by chemotherapy followed by radiation ...neoadjuvant chemotherapy was ...(neo)adjuvant chemotherapy can be considered in unresectable cases, as we ...
6
Results of a phase II open label, non randomized trial of cisplatin chemotherapy in patients with BRCA1 positive metastatic breast cancer
... a neo-adjuvant treatment of breast ...received neo-adjuvant chemotherapy, 10 of 12 women with a BRCA1 mutation who were given cis- platin experienced a complete pathologic response ...
8
NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
... from neo-adjuvant CRT as well as participation in the MRC OE05 trial had discouraged rou- tine use of neo-adjuvant ...with neo-adjuvant chemotherapy alone remains poor and ...
9
Effectiveness of adjuvant chemotherapy for elderly patients with lymph node positive colorectal cancer
... vant chemotherapy (NAC) is usually administered to patients with locally advanced colorectal cancer, the present study excluded 11 patients who received NAC to avoid confounding effects on ...
7
Clinicopathological Characteristics of Male Breast Cancer
... Department of Surgery, Yonsei University College of Medicine, in Seoul, Korea, between July 1985 and May 2007. This sample represents 0.38% (20/ 5,229) of all BC treated at our institution during the same period. Data ...
9
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real life data
... for adjuvant chemo- ...of adjuvant mFOLFIRINOX in the overall cohort of resected pancreatic cancer patients since 62% of our patients received adjuvant chemotherapy at all and only 20% ...
11
Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients
... The German Breast Group/Gynecologic Oncology Study Group (GeparQuattro) trial was also designed to evaluate the effect of trastuzumab on pCR rates in a group of breast cancer patients with locally advanced (T3 or T4), ...
6
MTX10 Moreover, such high doses facilitate MTX polyglutamate formation within the tumor cells and
... entry of the drug by a low affinity, high capacity carrier system 9 . Erythrocytes MTX profile during these 4 courses is shown in Figure 3. In all the infusions, there was substantial entry of the drug (> 104 M) into ...
7